{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:18:53Z","timestamp":1778537933289,"version":"3.51.4"},"reference-count":53,"publisher":"Oncology Nursing Society (ONS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1188\/07.cjon.53-63","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:42:38Z","timestamp":1187865758000},"page":"53-63","source":"Crossref","is-referenced-by-count":16,"title":["Hematopoietic Stem Cell Transplantation: Implications for Critical Care Nurses"],"prefix":"10.1188","volume":"11","author":[{"given":"Marlon G.","family":"Saria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy K.","family":"Gosselin-Acomb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Afessa, B., Tefferi, A., Dunn, W.F., Litzow, M.R., & Peters, S.G. (2003). Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. <i>Critical Care Medicine<\/i>, <b>31<\/b>, 1715-1721.","DOI":"10.1097\/01.CCM.0000065761.51367.2D"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Barnes, R.A., & Stallard, N. (2001). Severe infections after bone marrow transplantation. <i>Current Opinion in Critical Care<\/i>, <b>7<\/b>, 362-366.","DOI":"10.1097\/00075198-200110000-00008"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Benoit, D.D., Vandewoude, K.H., Decruyenaere, J.M., Hoste, E.A., & Colardyn, F.A. (2003). Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. <i>Critical Care Medicine<\/i>, <b>31<\/b>, 104-112.","DOI":"10.1097\/00003246-200301000-00017"},{"key":"E00004","unstructured":"Bevans, M., & Shelburne, N. (2004). Hematopoietic stem cell transplantation. <i>Clinical Journal of Oncology Nursing<\/i>, <b>8<\/b>, 541-543."},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Capizzi, S.A., Kumar, S., Huneke, N.E., Gertz, M.A., Inwards, D.J., Litzow, M.R., et al. (2001). Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. <i>Bone Marrow Transplantation<\/i>, <b>27<\/b>, 1299-1303.","DOI":"10.1038\/sj.bmt.1703075"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Coppell, J.A., Brown, S.A., & Perry, D.J. (2003). Veno-occlusive disease: Cytokines, genetics, and haemostasis. <i>Blood Reviews<\/i>, <b>17<\/b>, 63-70.","DOI":"10.1016\/S0268-960X(03)00002-X"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Deeg, H.J. (2003). New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects. <i>International Journal of Hematology<\/i>, <b>77<\/b>, 15-21.","DOI":"10.1007\/BF02982598"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Diaconescu, R., Flowers, C.R., Storer, B., Sorror, M.L., Maris, M.B., Maloney, D.G., et al. (2004). Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. <i>Blood<\/i>, <b>104<\/b>, 1550-1558.","DOI":"10.1182\/blood-2004-03-0804"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Dudek, A.Z., Mahaseth, H., DeFor, T.E., & Weisdorf, D.J. (2003). Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes. <i>Biology of Blood and Marrow Transplantation<\/i>, <b>9<\/b>, 657-666.","DOI":"10.1016\/S1083-8791(03)00242-8"},{"key":"E00010","unstructured":"Ferrara, J.L., & Yanik, G. (2005). Acute graft versus host disease: Pathophysiology, risk factors, and prevention strategies. <i>Clinical Advances in Hematology and Oncology<\/i>, <b>3<\/b>, 415-419, 428."},{"key":"E00011","unstructured":"Gobel, B. (2005). Metabolic emergencies. In J.K. Itano & K.N. Taoka (Eds.), <i>Core curriculum for oncology nursing<\/i> (4th ed., pp. 383-421). Pittsburgh, PA: Oncology Nursing Society."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Gorak, E., Geller, N., Srinivasan, R., Espinoza-Delgado, I., Donohue, T., Barrett, A.J., et al. (2005). Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: Incidence and effects on survival. <i>Biology of Blood and Marrow Transplantation<\/i>, <b>11<\/b>, 542-550.","DOI":"10.1016\/j.bbmt.2005.04.009"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Jackson, S.R., Tweeddale, M.G., Barnett, M.J., Spinelli, J.J., Sutherland, H.J., Reece, D.E., et al. (1998). Admission of bone marrow transplant recipients to the intensive care unit: Outcome, survival and prognostic factors. <i>Bone Marrow Transplantation<\/i>, <b>21<\/b>, 697-704.","DOI":"10.1038\/sj.bmt.1701158"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Jaksch, M., & Mattsson, J. (2005). The pathophysiology of acute graft-versus-host disease. <i>Scandinavian Journal of Immunology<\/i>, <b>61<\/b>, 398-409.","DOI":"10.1111\/j.1365-3083.2005.01595.x"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Kansu, E. (2004). The pathophysiology of chronic graft-versus-host disease. <i>International Journal of Hematology<\/i>, <b>79<\/b>, 209-215.","DOI":"10.1532\/IJH97.04015"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Kantrow, S.P., Hackman, R.C., Boeckh, M., Myerson, D., & Crawford, S.W. (1997). Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation. <i>Transplantation<\/i>, <b>63<\/b>, 1079-1086.","DOI":"10.1097\/00007890-199704270-00006"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Khurshid, I., & Anderson, L.C. (2002). Non-infectious pulmonary complications after bone marrow transplantation. <i>Postgraduate Medical Journal<\/i>, <b>78<\/b>, 257-262.","DOI":"10.1136\/pmj.78.919.257"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Kotloff, R.M., Ahya, V.N., & Crawford, S.W. (2004). Pulmonary complications of solid organ and hematopoietic stem cell transplantation. <i>American Journal of Respiratory and Critical Care Medicine<\/i>, <b>170<\/b>, 22-48.","DOI":"10.1164\/rccm.200309-1322SO"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Kumar, S., DeLeve, L.D., Kamath, P.S., & Tefferi, A. (2003). Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. <i>Mayo Clinic Proceedings<\/i>, <b>78<\/b>, 589-598.","DOI":"10.4065\/78.5.589"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Leather, H. (2004). Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: What every transplanter needs to know. <i>Bone Marrow Transplantation<\/i>, <b>33<\/b>, 137-152.","DOI":"10.1038\/sj.bmt.1704316"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Vogelsang, G., Gilman, A., Weisdorf, D.J., Pavletic, S., Antin, J.H., et al. (2002). A survey of diagnosis, management, and grading of chronic GVHD. <i>Biology of Blood and Marrow Transplantation<\/i>, <b>8<\/b>, 32-39.","DOI":"10.1053\/bbmt.2002.v8.pm11846354"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Leger, C.S., & Nevill, T.J. (2004). Hematopoietic stem cell transplantation: A primer for the primary care physician. <i>Canadian Medical Association Journal<\/i>, <b>170<\/b>, 1569-1577.","DOI":"10.1503\/cmaj.1011625"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Lewis, I.D., DeFor, T., & Weisdorf, D.J. (2000). Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: Cryptic etiology and uncertain therapy. <i>Bone Marrow Transplantation<\/i>, <b>26<\/b>, 539-543.","DOI":"10.1038\/sj.bmt.1702546"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Maiolino, A., Biasoli, I., Lima, J., Portugal, A.C., Pulcheri, W., & Nucci, M. (2003). Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. <i>Bone Marrow Transplantation<\/i>, <b>31<\/b>, 393-397.","DOI":"10.1038\/sj.bmt.1703855"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Mielcarek, M., Martin, P.J., Leisenring, W., Flowers, M.E., Maloney, D.G., Sandmaier, B.M., et al. (2003). Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. <i>Blood<\/i>, <b>102<\/b>, 756-762.","DOI":"10.1182\/blood-2002-08-2628"},{"key":"E00026","unstructured":"National Institutes of Health. (2004). Defibrotide in treating patients with liver damage following peripheral stem cell transplantation. Retrieved November 15, 2005, from <a target=\"_blank\" href='http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00003966'>http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00003966<\/a>"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Ozer, H., Armitage, J.O., Bennett, C.L., Crawford, J., Demetri, G.D., Pizzo, P.A., et al. (2000). 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidencebased, clinical practice guidelines. <i>Journal of Clinical Oncology<\/i>, <b>18<\/b>, 3558-3585.","DOI":"10.1200\/JCO.2000.18.20.3558"},{"key":"E00028","unstructured":"Pallera, A.M., & Schwartzberg, L.S. (2004). Managing the toxicity of hematopoietic stem cell transplant. <i>Journal of Supportive Oncology<\/i>, <b>2<\/b>, 223-237."},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Price, K.J., Thall, P.F., Kish, S.K., Shannon, V.R., & Andersson, B.S. (1998). Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. <i>American Journal of Respiratory and Critical Care Medicine<\/i>, <b>158<\/b>, 876-884.","DOI":"10.1164\/ajrccm.158.3.9711076"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Rabitsch, W., Deviatko, E., Keil, F., Herold, C., Dekan, G., Greinix, H., et al. (2001). Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. <i>Transplantation<\/i>, <b>71<\/b>, 1341-1343.","DOI":"10.1097\/00007890-200105150-00028"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Raptis, A., Mavroudis, D., Suffredini, A., Molldrem, J., Van Rhee, F., Childs, R., et al. (1999). High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. <i>Bone Marrow Transplantation<\/i>, <b>24<\/b>, 879-883.","DOI":"10.1038\/sj.bmt.1701995"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Resnick, I.B., Shapira, M.Y., & Slavin, S. (2005). Nonmyeloablative stem cell transplantation and cell therapy for malignant and nonmalignant diseases. <i>Transplant Immunology<\/i>, <b>14<\/b>, 207-219.","DOI":"10.1016\/j.trim.2005.03.009"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Roychowdhury, M., Pambuccian, S.E., Aslan, D.L., Jessurun, J., Rose, A.G., Manivel, J.C., et al. (2005). Pulmonary complications after bone marrow transplantation: An autopsy study from a large transplantation center. <i>Archives of Pathology and Laboratory Medicine<\/i>, <b>129<\/b>, 366-371.","DOI":"10.5858\/2005-129-366-PCABMT"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Rubenfeld, G.D., & Crawford, S.W. (1996). Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines. <i>Annals of Internal Medicine<\/i>, <b>125<\/b>, 625-633.","DOI":"10.7326\/0003-4819-125-8-199610150-00001"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Scott, P.H., Morgan, T.J., Durrant, S., & Boots, R.J. (2002). Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. <i>Anaesthesia and Intensive Care<\/i>, <b>30<\/b>, 289-294.","DOI":"10.1177\/0310057X0203000336"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Shaffer, S., & Wilson, J.N. (1993). Bone marrow transplantation: Critical care implications. <i>Critical Care Nursing Clinics of North America<\/i>, <b>5<\/b>, 531-542.","DOI":"10.1016\/S0899-5885(18)30557-4"},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"Shankar, G., & Cohen, D. (2001). Idiopathic pneumonia syndrome after bone marrow transplantation: The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. <i>International Journal of Experimental Pathology<\/i>, <b>82<\/b>, 101-113.","DOI":"10.1111\/j.1365-2613.2001.iep182.x"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Sharma, S., Nadrous, H.F., Peters, S.G., Tefferi, A., Litzow, M.R., Aubry, M.C., et al. (2005). Pulmonary complications in adult blood and marrow transplant recipients: Autopsy findings. <i>Chest<\/i>, <b>128<\/b>, 1385-1392.","DOI":"10.1378\/chest.128.3.1385"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Shivnan, J., Shelton, B.K., & Onners, B.K. (1996). Bone marrow transplantation: Issues for critical care nurses. <i>AACN Clinical Issues<\/i>, <b>7<\/b>, 95-108.","DOI":"10.1097\/00044067-199602000-00008"},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Shorr, A.F., Moores, L.K., Edenfield, W.J., Christie, R.J., & Fitzpatrick, T.M. (1999). Mechanical ventilation in hematopoietic stem cell transplantation: Can we effectively predict outcomes? <i>Chest<\/i>, <b>116<\/b>, 1012-1018.","DOI":"10.1378\/chest.116.4.1012"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Silfvast, T., Pettila, V., Ihalainen, A., & Elonen, E. (2003). Multiple organ failure and outcome of critically ill patients with haematological malignancy. <i>Acta Anaesthesiologica Scandinavica<\/i>, <b>47<\/b>, 301-306.","DOI":"10.1034\/j.1399-6576.2003.00058.x"},{"key":"E00042","doi-asserted-by":"crossref","unstructured":"Simon, M., Hahn, T., Ford, L.A., Anderson, B., Swinnich, D., Baer, M.R., et al. (2001). Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: Possible beneficial use of low molecular weight heparin. <i>Bone Marrow Transplantation<\/i>, <b>27<\/b>, 627-633.","DOI":"10.1038\/sj.bmt.1702854"},{"key":"E00043","doi-asserted-by":"crossref","unstructured":"Soubani, A.O., Kseibi, E., Bander, J.J., Klein, J.L., Khanchandani, G., Ahmed, H.P., et al. (2004). Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. <i>Chest<\/i>, <b>126<\/b>, 1604-1611.","DOI":"10.1378\/chest.126.5.1604"},{"key":"E00044","doi-asserted-by":"crossref","unstructured":"Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., et al. (2004). Palifermin for oral mucositis after intensive therapy for hematologic cancers. <i>New England Journal of Medicine<\/i>, <b>351<\/b>, 2590-2598.","DOI":"10.1056\/NEJMoa040125"},{"key":"E00045","doi-asserted-by":"crossref","unstructured":"Srinivas, T.R., Meier-Kriesche, H.U., & Kaplan, B. (2005). Pharmacokinetic principles of immunosuppressive drugs. <i>American Journal of Transplantation<\/i>, <b>5<\/b>, 207-217.","DOI":"10.1111\/j.1600-6143.2005.00748.x"},{"key":"E00046","doi-asserted-by":"crossref","unstructured":"Sullivan, K.M., Dykewicz, C.A., Longworth, D.L., Boeckh, M., Baden, L.R., Rubin, R.H., et al. (2001). Preventing opportunistic infections after hematopoietic stem cell transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation practice guidelines and beyond. <i>Hematology<\/i>, 392-421.","DOI":"10.1182\/asheducation-2001.1.392"},{"key":"E00047","doi-asserted-by":"crossref","unstructured":"Trifilio, S., Verma, A., & Mehta, J. (2004). Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: Heterogeneity of current clinical practice. <i>Bone Marrow Transplantation<\/i>, <b>33<\/b>, 735-739.","DOI":"10.1038\/sj.bmt.1704423"},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Wach, M., Dmoszynska, A., Wasik-Szczepanek, E., Pozarowski, A., Drop, A., & Szczepanek, D. (2004). Neutropenic enterocolitis: A serious complication during the treatment of acute leukemias. <i>Annals of Hematology<\/i>, <b>83<\/b>, 522-526.","DOI":"10.1007\/s00277-003-0815-x"},{"key":"E00049","doi-asserted-by":"crossref","unstructured":"Wadleigh, M., Ho, V., Momtaz, P., & Richardson, P. (2003). Hepatic veno-occlusive disease: Pathogenesis, diagnosis and treatment. <i>Current Opinion in Hematology<\/i>, <b>10<\/b>, 451-462.","DOI":"10.1097\/00062752-200311000-00010"},{"key":"E00050","doi-asserted-by":"crossref","unstructured":"Weisdorf, D.J. (2003). Diffuse alveolar hemorrhage: An evolving problem? <i>Leukemia<\/i>, <b>17<\/b>, 1049-1050.","DOI":"10.1038\/sj.leu.2402921"},{"key":"E00051","doi-asserted-by":"crossref","unstructured":"West, F., & Mitchell, S.A. (2004). Evidence-based guidelines for the management of neutropenia following outpatient hematopoietic stem cell transplantation. <i>Clinical Journal of Oncology Nursing<\/i>, <b>8<\/b>, 601-613.","DOI":"10.1188\/04.CJON.601-613"},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Wujcik, D., Ballard, B., & Camp-Sorrell, D. (1994). Selected complications of allogeneic bone marrow transplantation. <i>Seminars in Oncology Nursing<\/i>, <b>10<\/b>, 28-41.","DOI":"10.1016\/S0749-2081(05)80043-9"},{"key":"E00053","doi-asserted-by":"crossref","unstructured":"Zuccotti, G., Strasfeld, L., & Weinstock, D.M. (2005). New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients. <i>Expert Opinion on Pharmacotherapy<\/i>, <b>6<\/b>, 1669-1679.","DOI":"10.1517\/14656566.6.10.1669"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/J7N214W7807W8RP2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:14Z","timestamp":1763754674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/11\/1\/hematopoietic-stem-cell-transplantation-implications-critical-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["J7N214W7807W8RP2"],"URL":"https:\/\/doi.org\/10.1188\/07.cjon.53-63","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,1]]}}}